Day One Biopharmaceuticals (DAWN) Revenue (2020 - 2025)
Day One Biopharmaceuticals (DAWN) revenue from Mar 31, 2020 to Dec 31, 2025. The TTM Day One Biopharmaceuticals (DAWN) revenue is $158M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Day One Biopharmaceuticals (DAWN) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +20.61% |
Annual Revenue change of Day One Biopharmaceuticals (DAWN)
| Year | Revenue | Change |
|---|---|---|
| 2025 | $158M | +20.60% |
| 2024 | $131M | N/A |
| 2023 | $0 | N/A |
| 2022 | $0 | N/A |
| 2021 | $0 | N/A |
| 2020 | $0 | N/A |
| 2019 | $0 | N/A |